Mini-Review: Bmx Kinase Inhibitors for Cancer Therapy

E-ISSN： 2212-3970|8|3|228-238

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.8, Iss.3, 2013-09, pp. : 228-238

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evidence for Anti-Cancer Properties of Blueberries: A Mini-Review

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 8, 2013-10 ,pp. : 1142-1148

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Focal Adhesion Kinase Inhibitors in Cancer Therapy

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 7, 2011-09 ,pp. : 638-642

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Oncogenic Protein Kinase Inhibitors for Cancer Therapy

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 4, Iss. 5, 2004-09 ,pp. : 449-455

Bentham Science Publishers

Access to resources Recommend Favorite

Qualitative age interactions in breast cancer studies: a mini-review

By Jatoi Ismail Anderson William F

Future Oncology, Vol. 6, Iss. 11, 2010-11 ,pp. : 1781-1788

Future Medicine

Access to resources Recommend Favorite

Systemic therapy of kidney cancer: tyrosine kinase inhibitors, antiangiogenesis or IL-2?

By Kirkali Ziya Tüüzel Emre

Future Oncology, Vol. 5, Iss. 6, 2009-08 ,pp. : 871-888

Future Medicine

Access to resources Recommend Favorite